Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.
作者信息
Yamasoba Daichi, Uriu Keiya, Plianchaisuk Arnon, Kosugi Yusuke, Pan Lin, Zahradnik Jiri, Ito Jumpei, Sato Kei
机构信息
Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; Faculty of Medicine, Kobe University, Kobe, Japan.
Division of Systems Virology, Department of Microbiology and Immunology, The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, and Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
出版信息
Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3.
Abstract
摘要
相似文献
1
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant.严重急性呼吸综合征冠状病毒2型奥密克戎XBB.1.16变体的病毒学特征
Lancet Infect Dis. 2023 Jun;23(6):655-656. doi: 10.1016/S1473-3099(23)00278-5. Epub 2023 May 3.
2
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant.奥密克戎 XBB.1.5 变异株的病毒学特征。
Nat Commun. 2024 Feb 8;15(1):1176. doi: 10.1038/s41467-024-45274-3.
3
Editorial: The XBB.1.5 ('Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread.社论：奥密克戎 SARS-CoV-2 的 XBB.1.5（“Kraken”）亚变体及其快速全球传播。
Med Sci Monit. 2023 Feb 1;29:e939580. doi: 10.12659/MSM.939580.
4
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.早期估计，二价 mRNA 加强针在预防免疫功能正常成年人因奥密克戎 BA.5-和 XBB/XBB.1.5 相关亚谱系导致的有症状 SARS-CoV-2 感染方面的有效性-增加社区获得检测计划，美国，2022 年 12 月至 2023 年 1 月。
MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-124. doi: 10.15585/mmwr.mm7205e1.
5
Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis.与 SARS-CoV-2 XBB 变异株相关的严重结局的观察性分析。
J Clin Virol. 2023 Aug;165:105500. doi: 10.1016/j.jcv.2023.105500. Epub 2023 Jun 1.
6
SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects - correspondence.严重急性呼吸综合征冠状病毒2变种奥密克戎XBB.1.5：挑战与前景——通信
Int J Surg. 2023 Apr 1;109(4):1054-1055. doi: 10.1097/JS9.0000000000000276.
7
Emergence and geographic dominance of Omicron subvariants XBB/XBB.1.5 and BF.7 - the public health challenges.奥密克戎亚变体XBB/XBB.1.5和BF.7的出现及其在地理上的优势——公共卫生挑战
Int J Infect Dis. 2023 Mar;128:307-309. doi: 10.1016/j.ijid.2023.01.024. Epub 2023 Jan 19.
8
Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB.1.5, BQ.1, BQ.1.1, BF.7 and BA.2.75.2.新型冠状病毒奥密克戎亚变体XBB.1.5、BQ.1、BQ.1.1、BF.7和BA.2.75.2的抗原特性
Signal Transduct Target Ther. 2023 Mar 15;8(1):125. doi: 10.1038/s41392-023-01391-x.
9
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant.与德尔塔变异株相比，奥密克戎变异株的病毒载量较低，导致快速抗原检测的敏感性降低。
Microbiol Spectr. 2022 Oct 26;10(5):e0192222. doi: 10.1128/spectrum.01922-22. Epub 2022 Sep 20.
10
Antigenic mapping of emerging SARS-CoV-2 omicron variants BM.1.1.1, BQ.1.1, and XBB.1.新型严重急性呼吸综合征冠状病毒2（SARS-CoV-2）奥密克戎变种BM.1.1.1、BQ.1.1和XBB.1的抗原图谱分析
Lancet Microbe. 2023 May;4(5):e294-e295. doi: 10.1016/S2666-5247(22)00384-6. Epub 2023 Jan 16.
引用本文的文献
1
Multiscale Modeling and Dynamic Mutational Profiling of Binding Energetics and Immune Escape for Class I Antibodies with SARS-CoV-2 Spike Protein: Dissecting Mechanisms of High Resistance to Viral Escape Against Emerging Variants.针对与SARS-CoV-2刺突蛋白结合的I类抗体的结合能和免疫逃逸的多尺度建模与动态突变分析：剖析对病毒逃逸针对新出现变体的高抗性机制。
Viruses. 2025 Jul 23;17(8):1029. doi: 10.3390/v17081029.
2
Early detection of emerging SARS-CoV-2 Variants from wastewater through genome sequencing and machine learning.通过基因组测序和机器学习从废水中早期检测新出现的严重急性呼吸综合征冠状病毒2变体。
Nat Commun. 2025 Jul 8;16(1):6272. doi: 10.1038/s41467-025-61280-5.
3
Enhanced reverse zoonotic potential and immune evasion by omicron JN.1 variant.奥密克戎JN.1变体增强的反向人畜共患病潜力和免疫逃逸能力。
iScience. 2025 Jun 6;28(7):112824. doi: 10.1016/j.isci.2025.112824. eCollection 2025 Jul 18.
4
XBB.1.5 RBD-Based Bivalent Vaccines Induced Antibody Responses Against SARS-CoV-2 Variants in Mice.基于XBB.1.5 RBD的二价疫苗在小鼠中诱导了针对新冠病毒变体的抗体反应。
Vaccines (Basel). 2025 May 20;13(5):543. doi: 10.3390/vaccines13050543.
5
A protein language model for exploring viral fitness landscapes.一种用于探索病毒适应性景观的蛋白质语言模型。
Nat Commun. 2025 May 13;16(1):4236. doi: 10.1038/s41467-025-59422-w.
6
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）BQ.1.1和XBB.1.16谱系中的NSP6-L260F替代可弥补由NSP13和NSP14突变导致的病毒聚合酶活性降低。
J Virol. 2025 Jun 17;99(6):e0065625. doi: 10.1128/jvi.00656-25. Epub 2025 May 13.
7
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients.科兴疫苗接种者中针对新冠病毒变异株的RBD-ACE2阻断抗体与结合抗体之间的时间相关性及其在新冠患者中的持久性
Sci Rep. 2025 May 6;15(1):15831. doi: 10.1038/s41598-025-98627-3.
8
Exploring Temporal and Spatial Characteristics of Serious Adverse Event Reports Following COVID-19 Bivalent Vaccines.探索新冠病毒二价疫苗接种后严重不良事件报告的时空特征。
Res Sq. 2025 Mar 3:rs.3.rs-6096098. doi: 10.21203/rs.3.rs-6096098/v1.
9
Epimaps of the SARS-CoV-2 Receptor-Binding Domain Mutational Landscape: Insights into Protein Stability, Epitope Prediction, and Antibody Binding.严重急性呼吸综合征冠状病毒2受体结合域突变景观的表观图谱：对蛋白质稳定性、表位预测和抗体结合的见解
Biomolecules. 2025 Feb 18;15(2):301. doi: 10.3390/biom15020301.
10
Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies.针对奥密克戎变体的广谱中和抗体组的结合决定因素和免疫逃逸热点的定量表征与预测：SARS-CoV-2刺突复合物与抗体的原子模型
Biomolecules. 2025 Feb 8;15(2):249. doi: 10.3390/biom15020249.
Zotero 插件